Clearmind Medicine Advances Global Intellectual Property Portfolio with Japanese Patent Filing for Innovative Psychedelic- Based Depression Treatment

Go back to Clearmind Medicine Advances Global Intellectual Property Portfolio with Japanese Patent Filing for Innovative Psychedelic- Based Depression Treatment
(NASDAQ: CMND) Delayed: 2.34 --0 (-0%)
Previous Close $2.34    52 Week High
Open $2.34    52 Week Low
Day High $2.34    P/E N/A 
Day Low $2.34    EPS
Volume 450